Rapport Therapeutics Inc (RAPP)

Investing Cash Flow

$25.60M

Quarterly · Period ending: · USD

RAPP logo

RAPP Investing Cash Flow

Latest reported$25.60M
RAPP Quarterly Cash from Investing (-$61.00K → $25.60M)
High-resolution chart · PNG

RAPP investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rapport Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
25,600,000
37,941,000
-174,324,000
-56,776,000
22,596,000
21,031,000
31,930,000
-53,041,000
-107,104,000
-41,926,000
-78,661,000
-52,000
-86,000
-61,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.